Olukemi Esan, MB
Hematology ·
Female ·
Age 47
0.0 based on 0 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Olukemi Esan, MB is a hematology specialist in Pittsburgh, PA. She graduated from Univ Ibadan and specializes in hematology and hematopathology.
Insurance Accepted
- Blue Cross Blue Shield
- MultiPlan
*Please verify this information when scheduling an appointment.
Background Check
Healthgrades does not collect malpractice claims information for Pennsylvania
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Olukemi Esan's Top Procedures and Conditions
Treatment Frequency
Blood Disorders
normal
normal
Treatment Frequency
Olukemi Esan treats Blood Disorders more than 58% of her peers
Olukemi Esan treats this condition more than 58% of her peers
Cancer
normal
normal
Treatment Frequency
Olukemi Esan treats Cancer more than 49% of her peers
Olukemi Esan treats this condition more than 49% of her peers
Rating Includes other areas of care:
- Adenoid Cystic Carcinoma
- Adolescent Cancer
- Adrenal Cortical Carcinoma
- Adrenal Gland Cancer
- Adult Cerebral Astrocytoma
- Adult Small Cell Lung Cancer
- Ampullary Carcinoma
- Anal and Rectal Cancer
- Anal Cancer
- Anaplastic Oligodendroglioma
- Angiosarcoma of the Breast
- Appendix Cancer
- Astrocytoma
- Basal Cell Carcinoma (BCC)
- Basal Type Breast Cancer
- Benign Astrocytoma
- Bile Duct Cancer
- Biliary Cancer
- Bladder Cancer
- Blood Cancer
- Bone Cancer
- Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Brainstem Glioma
- Breast Cancer
- Breast Cancer Recurrence
- Bronchioalveolar Carcinoma
- Bronchogenic Carcinoma
- Cancer of Floor of Mouth
- Cerebellar Astrocytoma
- Cerebral Astrocytoma
- Cervical Cancer
- Cholangiocarcinoma
- Chordoma
- Choriocarcinoma
- Chromophobe Renal Cell Carcinoma
- Clear Cell Adenocarcinoma
- Clear Cell Renal Cell Carcinoma
- Colorectal Cancer
- Cutaneous Squamous Cell Carcinoma
- Distal Colorectal Cancer
- Distal Gastrointestinal Tract Cancers
- Ductal Carcinoma in Situ
- Duodenal Cancer
- Ear Cancer
- Endocrine Cancer
- Endometrial Cancer
- ENT Cancer
- Epidermoid Carcinoma
- Epithelial-Myoepithelial Carcinoma
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Eye Cancer
- Facial Skin Cancer
- Fallopian Tube Cancer
- Familial Colorectal Cancer
- Familial Pancreatic Cancer
- Familial Renal Cancer
- Familial Renal Cell Carcinoma
- Fibrolamellar Hepatocellular Carcinoma
- Follicular Adenocarcinoma
- Follicular Thyroid Cancer
- Gall Bladder Cancer
- Gallbladder & Biliary Tract Cancer
- Gastric Cancer, Borrmann 4
- Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
- Genital System Cancer
- Genitourinary Cancers
- Gland Cancer
- Glassy Cell Carcinoma
- Glioma
- Gliomatosis Cerebri
- Gynecologic Cancer
- Hamartomatous Colorectal Cancer
- Heart Cancer
- Hepatobiliary Cancer
- Hepatocellular Cancer
- Hepatocellular Carcinoma
- Hip Cancer
- Hypopharyngeal Cancer
- Inflammatory Breast Cancer
- Infundibulocystic Basal Cell Carcinoma
- Intestinal Cancer
- Intrahepatic Cholangiocarcinoma
- Invasive Breast Cancer
- Invasive Ductal Carcinoma
- Invasive Lobular Carcinoma
- Joint Cancer
- Juvenile Pilocytic Astrocytoma
- Laryngeal Cancer
- Laryngeal Carcinoma
- Limb Cancer
- Lip Cancer
- Liver Cancer
- Locally Advanced Breast Cancer
- Lung Cancer
- Lymphoma of the Breast
- Male Breast Cancer
- Male Genitourinary Cancer
- Malignant Astrocytoma
- Malignant Breast Tumor
- Malignant Glioma
- Mediastinal Cancer
- Medullary Thyroid Cancer
- Medulloblastoma
- Melanoma-Astrocytoma Syndrome
- Merkel Cell Cancer
- Metastatic Adrenal Gland Cancer
- Metastatic Blood Cancer
- Metastatic Bone Cancer
- Metastatic Breast Cancer
- Metastatic Cancer
- Metastatic Liver Cancer
- Metastatic Lymph Cancer
- Metastatic Nervous System Cancer
- Metastatic Prostate Cancer
- Metastatic Skin Cancer
- Metastatic Soft Tissue Cancer
- Metastatic Spinal Cord Cancer
- Metastatic Squamous Neck Cancer With Occult Primary
- MSI-H Colorectal Cancer
- MSI-L Colorectal Cancer
- MSS Colorectal Cancer
- Muscle Cancer
- Nasal Cavity Cancer
- Nasopharyngeal Cancer
- Neck Cancer
- Nerve Cancer
- Neuroendocrine Cancer
- Nevoid Basal Cell Carcinoma Syndrome
- Nodular Basal Cell Carcinoma
- Noduloulcerative Basal Cell Carcinoma
- Non-Melanoma Skin Cancer
- Nonpolyposis Colorectal Cancer, Familial
- Non-Small Cell Lung Cancer
- Nose Cancer
- Oligodendroglioma
- Oral Cancer
- Oral Squamous Cell Carcinoma
- Oropharyngeal Cancer
- Oropharyngeal Cancer, Adult
- Osteosarcoma of the Breast
- Ovarian Cancer
- Ovarian Epithelial Cancer
- Palate Cancer
- Pancreatic Cancer
- Pancreatic Islet Cell Cancer
- Papillary Renal Cell Carcinoma
- Papillary Thyroid Cancer
- Paranasal Sinus Cancer
- Parathyroid (Gland) Cancer
- Parathyroid Carcinoma
- Parotid Gland Cancer
- Pediatric Cancer
- Pelvic Cancer
- Penile Cancer
- Pharyngeal Cancer
- Pigmented Basal Cell Carcinoma
- Pleura Cancer
- Pre-Invasive Breast Cancer
- Primary Prostate Cancer
- Prostate Cancer
- Prostate Cancer - Hereditary - 1
- Prostate Cancer - Hereditary - 10
- Prostate Cancer - Hereditary - 11
- Prostate Cancer - Hereditary - 14
- Prostate Cancer - Hereditary - 2
- Prostate Cancer - Hereditary - 3
- Prostate Cancer - Hereditary - 4
- Prostate Cancer - Hereditary - 5
- Prostate Cancer - Hereditary - 6
- Prostate Cancer - Hereditary - 7
- Prostate Cancer - Hereditary - 8
- Prostate Cancer - Hereditary - 9
- Prostate Cancer - Hereditary - X-Linked 1
- Prostate Cancer - Hereditary - X-Linked 2
- Prostate Cancer - Hereditary -12
- Prostate Cancer - Hereditary -13
- Prostate Cancer - Hereditary -15
- Radiation-Induced Angiosarcoma of the Breast
- Rectal Cancer
- Renal (Kidney) Cancer
- Renal Cell Cancer
- Respiratory System Cancer
- Retinal Cancer
- Salivary Gland Cancer
- Sebaceous Gland Carcinoma
- Secretory Breast Carcinoma
- Sinonasal Undifferentiated Carcinoma
- Sinus Cancer
- Skin Cancer
- Small Cell Lung Cancer
- Spinal Cord Cancer
- Spleen Cancer
- Sporadic Colorectal Cancer
- Squamous Cell Carcinoma
- Squamous Cell Carcinoma of Conjunctiva
- Squamous Cell Carcinoma of Head and Neck
- Stomach and Small Intestine Cancer
- Stomach Cancer
- Stomach Cancer, Familial
- Superficial Basal Cell Carcinoma
- Supraglottic Laryngeal Cancer
- Testicular Cancer
- Thoracic Cancer
- Throat Cancer
- Thymus Cancer
- Thyroid Cancer
- Thyroid Cancer, Anaplastic
- Thyroid Cancer, Familial Medullary
- Thyroid Cancer, Hurthle Cell
- Tongue Cancer
- Trachea Cancer
- Transitional Cell Cancer
- Transitional Cell Carcinoma
- Tubular Carcinoma
- Urachal Cancer
- Ureteral Cancer
- Urinary Tract Cancer
- Uterine Cancer
- Vaginal Cancer
- Visual Pathway and Hypothalamic Glioma
- Vocal Cord Carcinoma
- Vulvar Cancer
Anemia
normal
normal
Treatment Frequency
Olukemi Esan treats Anemia more than 42% of her peers
Olukemi Esan treats this condition more than 42% of her peers
Rating Includes other areas of care:
- Acquired Aplastic Anemia
- Anemia of Pregnancy
- Aplastic Anemia
- Atypical Hemolytic Uremic Syndrome
- Autoimmune Hemolytic Anemia (AIHA)
- Chronic Anemia
- Cold Autoimmune Hemolytic Anemia
- Diamond-Blackfan Anemia
- D-Negative Hemolytic Uremic Syndrome (D - HUS)
- D-Negative Hemolytic Uremic Syndrome, Pregnancy Related
- D-Positive Hemolytic Uremic Syndrome (D + HUS)
- Hemolytic Anemia, Acquired Autoimmune
- Hemolytic Uremic Syndrome
- Hereditary Spherocytosis
- Iron Deficiency Anemia
- Megaloblastic Anemia
- Microcytic Hypochromic Anemia
- Myelpathic Anemia
- Neonatal Anemia
- Nutritional Anemia
- Nutritional Sideroblastic Anemia
- Pernicious Anemia
- Refractory Anemia With Excess Blasts
- Refractory Anemia With Excess Blasts-1
- Refractory Anemia With Excess Blasts-2
- Secondary Cold Autoimmune Hemolytic Anemia
- Sideroblastic Anemia
- Sideroblastic Anemia With Spinocerebellar Ataxia
- Sideroblastic Anemia, Pyridoxine-Responsive, Autosomal Recessive
- Warm Autoimmune Hemolytic Anemia
Olukemi Esan's conditions and procedures:
Acute Leukemia
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
All Lymphoma
Anemia
Autoimmune Diseases
Bleeding Disorders
Blood Disorders
Bone Cancer
Bone Disorders
Cancer
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia (CML)
Hodgkin's Disease
Leukocytosis
Lymphocytosis
Mantle Cell Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Neutropenia
Non-Hodgkin's Lymphoma
Pancytopenia
Polycythemia Rubra Vera
Pregnancy-Related Disorders
Reticulosarcoma
Thrombocytosis
Thrombosis
Vascular Disease
About Me
Biography
Olukemi Esan, MB is a hematology specialist in Pittsburgh, PA. She graduated from Univ Ibadan and specializes in hematology and hematopathology.
Specialties
- Hematology
- Hematopathology
Board Certifications
- Anatomic & Clinical Pathology
- Hematology & Pathology
Awards
- Healthgrades Honor Roll
Olukemi Esan's Reviews
Be the first to leave a review
How likely are you to recommendOlukemi Esan?
Overall Patient Satisfaction
Locations
Insurance accepted
Accepted insurance can change. Please double-check when making an appointment.
- Blue Cross Blue Shield
- Blue Card PPO
- MultiPlan
- MultiPlan PPO
- PHCS Network PPO
Compare Providers
More providers who are similar to Olukemi Esan
Show All Hematologists